NDC product
ACAM2000
NDC 71665-330 · Emergent Product Development Gaithersburg Inc.
Key facts
| Product NDC | 71665-330 |
|---|---|
| Proprietary name | ACAM2000 |
| Nonproprietary name | smallpox and mpox (vaccinia) vaccine, live |
| Substances | VACCINIA VIRUS STRAIN NEW YORK CITY BOARD OF HEALTH LIVE ANTIGEN |
| Dosage form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | PERCUTANEOUS |
| Labeler | Emergent Product Development Gaithersburg Inc. |
| Product type | VACCINE |
| Marketing category | BLA |
| Application number | BLA125158 |
| Pharmacologic classes | Actively Acquired Immunity [PE], Live Vaccinia Virus Vaccine [EPC], Smallpox Vaccine [CS], Vaccines, Live, Unattenuated [CS] |
| Marketing start | Aug 31, 2007 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: